Abstract:Objectives We aimed to investigate whether over-expression of miR-210, an oxide-related miR, could protect mesenchymal stromal cells (MSCs) against apoptosis induced by oxidative stress, and if so, what the potential mechanisms involved. Methods MSCs, derived from male SD rats, with forced expression of miR-210 or miR-null by lentivirus infection was incubated with or without Peroxide hydrogen (H2O2). The reactive oxygen species (ROS) accumulation in MSCs was detected by immunofluoresence probes; cellular survival was measured by MTT assay, Hochest staining and TUNEL examination; superoxidedismutase (SOD) activity and adecreaseinmalonaldehyde (MDA) content were analysed by ELISA assay; and the activation of c-Met pathway was quantified by immunoblot. After application of Crizotinib, an inhibitor specific to c-Met pathway, the above detections were investigated to clarify the mechanisms involved. In an in vivo experiment, the expression of sry gene was checked by quantitative PCR to compare the survival of MSCs-miR-210 and MSCs-miR-null in the infarcted myocardium of female rats on day 4 after transplantation; afterwards, echocardiology was applied to assess the cardiac remodelling and myocardial function in a 4-week follow-up. Results It was revealed that forced expression of miR-210 significantly decreased the apoptosis of MSCs against H2O2 compared with that of miR-null, indicated as follows: a notable decreases in ROS generation (2.34 ± 0.62 vs. 3.98 ± 0.57, P<0.05) and apoptotic indices [(15.3 ± 3.87)% vs. (33.8 ± 2.67)%, P<0.05]; a dramatic increase in cell viability (2.98 ± 0.67 vs. 1.00 ± 0.74, P<0.05), SOD activity (3.91 ± 0.28 vs. 1.00 ± 0.38, P<0.05) and MDA content (2.95 ± 0.41 vs. 1.00 ± 0.36, P<0.05), which was companied by a remarkable activation of c-Met pathway (2.87 ± 0.34 vs. 1.00 ± 0.52, P<0.05). Most importantly, each of the above beneficial effects was attenuated by Crizotinib (P all <0.05). Furthermore, transplantation of MSCs-miR-210 resulted in higher cell survival rates (2.86 ± 0.33 vs. 1.00 ± 0.37, P<0.05), therefore significantly improved cardiac remodelling [LVIDd: (5.38 ± 0.61) mm vs. (6.39 ± 0.67) mm, P<0.05; LVIDs: (4.92 ± 0.52) mm vs. (5.89 ± 0.51) mm, P<0.05;] and statistically ameliorated myocardial function [LVEF: (62.3 ± 5.32)% vs. (42.6 ± 4.38)%, P<0.05] than that of MSCs-miR-null. Conclusions MiR-210 over-expression may improve MSCs survival in an oxidative stress circumstances through anti-oxidation and c-Met pathways activation, thus enhances their therapeutic effect on myocardial infarction, suggesting that miR-210 was a potential intervention target in the cell-based treatment.

MicroRNA-210 mediates the protective effect of rosuvastatin on human mesenchymal stem cells apoptosis induced by tumor necrosis factor-α

GW24-e3699 Rosuvastatin protects cardiomyocytes from tumour necrosis factor-alpha induced apoptosis via microRNA-210 up-regulation

Simvastatin Protects Human Osteosarcoma Cells from Oxidative Stress-Induced Apoptosis Through Mitochondrial-Mediated Signaling

Rosiglitazone attenuates endothelial progenitor cell apoptosis induced by TNF-α via ERK/MAPK and NF-κB signal pathways.

GW24-e3739 MiR-210 Over-expression Enhances Mesenchymal Stromal Cells Survival in an Oxidative Stress Circumstance Though Anti-oxidation and C-Met Pathways Activation

Abstract 249: Mir-211 Regulates Bone Marrow Mesenchymal Stem Cells Migration Through Stat5a

miR-210 over-expression enhances mesenchymal stem cell survival in an oxidative stress environment through antioxidation and c-Met pathway activation

Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways

SRT1720 Pretreatment Promotes Mitochondrial Biogenesis of Aged Human Mesenchymal Stem Cells and Improves Their Engraftment in Postinfarct Nonhuman Primate Hearts.

Rosuvastatin Prevents Adipose-derived Mesenchymal Stem Cells from Hypoxia/Reoxygenation Injury through Activation of ERK and AKT

[Effects of Resveratrol on Aging of Mesenchymal Stem Cells and Its Mechanism].

The mitochondria‒paraspeckle axis regulates the survival of transplanted stem cells under oxidative stress conditions

Atorvastatin inhibits the H2O2-induced apoptosis of human vascular endothelial cells through a down-regulation of cleaved caspase-9/caspase-3

Lovastatin inhibits apoptosis of mesenchymal stem cells isolated from rat bone marrow

Rosuvastatin Treatment Activates JAK-STAT Pathway and Increases Efficacy of Allogeneic Mesenchymal Stem Cell Transplantation in Infarcted Hearts.

Abstract 13434: Cardioprotection of Rosuvastatin Against Cardiac Dysfunction after Coronary Microembolization Via Alleviating Inflammatory Induced Microinfarctions

Abstract 16252: MiRNA-24 Over-Expression Potentiates Mesenchymal Stem Cells Survival in the Infarcted Myocardium Through Autophagy Activation Via Targeting Rubicon

GW24-e2431 MicroRNA-210 Over-expression Activates Autophagy in Mesenchymal Stem Cells and Improves its Therapeutic Effect on the Myocardial Infarction: anin vitroandin vivoStudy

Rosuvastatin Regulates Osteogenic Differentiation of Mesenchymal Stem Cells Through Phosphatidylinositol-3-kinase/protein Kinase B

Rosuvastatin Alleviates Coronary Microembolization-Induced Cardiac Injury by Suppressing Nox2-Induced ROS Overproduction and Myocardial Apoptosis

Mesenchymal stem cell conditioned medium alleviates oxidative stress injury induced by hydrogen peroxide via regulating miR143 and its target protein in hepatocytes